May 15 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.63 10.67 13.63
(+18.4 pct) (+11.4 pct) (+7.9 pct)
Operating 1.62 839 mln 1.22
(+92.9 pct) (+3.0 pct) (-24.7 pct)
Recurring 1.60 702 mln 1.06
(+127.7 pct) (-34.2 pct) (-33.7 pct)
Net
Net 265 mln 452 mln 690 mln
(-41.4 pct) (-36.1 pct) (+160.1 pct)
EPS 32.73 yen 55.90 yen 85.12 yen
Ann Div 9.00 yen 9.00 yen 24.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 9.00 yen 9.00 yen 24.00 yen
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T